Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

ALX Oncology Holdings Inc. ALXO

Healthcare  —  Biotechnology
1.31 (0.05) (3.68%) as of 25 Sep
Market cap
$187.4M
P/E
0.0×
Insider Buys (last 12m)
Insider Buys alert about insiders buying in the last 12 month
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K
Quarterly (Descending) Quarterly (Ascending) Annual (Descending) Annual (Ascending)
Download Excel — free account

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Jun '26 Mar '26 Dec '25 Sep '25 Older periods
Cash and Short Term Investments 138.23 140.32 44.79 60.63

+8 more quarters
Total current assets 143.46 145.56 50.73 66.52
Property, Plant, Equpment (Net) 0.17 1.05 1.20 1.35
Long-Term Investments 15.15 28.78 3.49 5.84
Long-term assets (Other) 2.05 2.93 3.63 9.02
Total non-current assets 17.36 32.76 8.32 16.21
Total Assets 160.82 178.33 59.05 82.72
Accounts Payable 3.02 3.85 4.91 6.58
Accrued Expenses 11.75 11.11 14.42 16.79
Current Part of Debt — 5.22 5.22 4.35
Total current liabilities 14.78 20.18 24.55 27.72
Long Term Debt (Total) 9.71 3.30 4.53 5.76
Non-current Liabilities (Other) 0.15 3.51 3.98 4.44
Total non-current liabilities 9.86 6.80 8.51 10.20
Total liabilities 24.63 26.98 33.07 37.92
Additional Paid In Capital 894.99 892.20 748.72 744.67
Common Stock (Net) 0.14 0.14 0.05 0.05
Retained Earnings (758.71) (740.74) (722.82) (699.97)
Common Equity (Total) 136.19 151.35 25.98 44.80
Shareholders Equity (Total) 136.19 151.35 25.98 44.80
Shareholders Equity and Liabilities (Total) 160.82 178.33 59.05 82.72
Shares (Common) 138.22 134.54 54.39 53.58
Shareholders Equity (Tangible) 136.19 151.35 25.98 44.80
Net Debt (128.52) (131.81) (35.04) (50.51)
Total Debt 9.71 8.51 9.75 10.11

Fold the line items

In millions of $ except per-share values · columns are period end dates